Bum Jobs Number Boo...
Health Care: Drugs
Bristol-Myers Squibb Company (BMY: NYSE)
$33.33 -0.01 | -0.03%
06/01/12 - 04:00 PM ET
12.35M / 9.55M
Vol / Avg. Vol:32.87 / 33.34
Open / Prev. Close:32.83 - 33.34
Today's Range:25.69 - 35.44
52 Wk Range:-5.39%
Performance YTD:TheStreet Rating:
Portfolios with BMY
- Portfolio NameUser Type
- Userralphd5-12
- UserDiversified Balanced Retire...
- Contributor10 New Low Volatility Stock...
- UserJFleckensteins favorite picks
- Userdennis diamonds
- ContributorHigh Volume Technicals for ...
- UserJimboPhi
- Contributor10 Longest-Held Stocks of T...
- UserEddie 08225
- UserKAREL VON ZOETE
Latest BMY Headlines from TheStreet
- Stocks to Watch: Salesforce.com, Bristol-Myers (Update 1) 06.04.12 | 08:06 am
- ASCO '12 Stocks: Winners and Losers 06.04.12 | 06:06 am
- ASCO '12: Ariad Pharma Leukemia Drug Posts Improved Response Rates 06.04.12 | 12:06 am
- Bristol Drug Unlocks Immune System to Shrink Tumors 06.02.12 | 12:06 am
- ASCO '12: Bristol Drug Unlocks Immune System to Target Cancer 06.01.12 | 01:06 pm
- Bristol-Myers Squibb Company (BMY): Today's Featured Health Care Winner 05.24.12 | 05:05 pm
- Celldex Targeted Drug Shrinks Breast Cancer 05.23.12 | 04:05 pm
- Analysts' Actions: AZO, BMY, LLY, MS 05.18.12 | 09:05 am
- Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Loser 05.17.12 | 05:05 pm
- Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Loser 05.08.12 | 04:05 pm
Press Releases for BMY
- Investigational Anti-PD-1 Immunotherapy BMS-936558 Showed Clinical Activity In Phase 1 Trial Of Patients With Previously-Treated Non-Small-Cell Lung Cancer, Metastatic Melanoma And Renal Cell Cancer - Business Wire 06.02.12 | 12:06 am
- Bristol-Myers Squibb To Take Part In The Goldman Sachs 33rd Annual Global Healthcare Conference - Business Wire 05.31.12 | 04:05 pm
- Bristol-Myers Squibb Announces Global Collaboration With Leading Academic Institutions To Advance Science Of Immuno-Oncology - Business Wire 05.29.12 | 08:05 am
- Bristol-Myers Squibb To Take Part In Sanford Bernstein’s 28th Annual Strategic Decisions Conference - Business Wire 05.24.12 | 10:05 am
- U.S. FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing Facility For Production Of ORENCIA® (abatacept) - Business Wire 05.15.12 | 11:05 am
- Bristol-Myers Squibb Foundation Announces $15 Million Expansion Of Together On Diabetes® To China And India - Business Wire 05.15.12 | 10:05 am
- "My Family Learned Firsthand That Melanoma Is Not An Opponent To Be Underestimated," Said Coach Bill Cowher. (Photo: Business Wire) - Business Wire 05.15.12 | 08:05 am
- Former Pro Football Coach Bill Cowher Teams Up With Leading Advocacy Groups To Launch Melanoma Exposedâ¢, An Educational Campaign To Raise Awareness Of The Most Deadly Form Of Skin Cancer - PR Newswire 05.15.12 | 08:05 am
- Bristol-Myers Squibb To Present New Data On ORENCIA(R)â¼ (abatacept) At The European League Against Rheumatism (EULAR) 2012 Congress - PR Newswire 05.14.12 | 08:05 am
- Bristol-Myers Squibb To Present New Data On ORENCIA® (abatacept) At The European League Against Rheumatism (EULAR) 2012 Congress - Business Wire 05.14.12 | 08:05 am
Partner Headlines for BMY
- Groupon and Dell Lead These 3 Stocks to FRESH 52-Week Lows - Wall St. Cheat Sheet 06.04.12 | 09:06 am
- Teva Spikes Higher as Chairman Purchases One Million Shares - Benzinga 06.02.12 | 11:06 am
- Do Merck's Major Stockholders See $40 Per Share Down the 2012 Road? - Wall St. Cheat Sheet 05.30.12 | 10:05 am
- Healthcare Biz Recap: Teva's Counterfeit Problem, Hopes for Bristol-Myers - Wall St. Cheat Sheet 05.30.12 | 07:05 am
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 - Seeking Alpha 05.25.12 | 08:05 pm
- Insider S&P 500 Stock Trades to Watch This Week - Wall St. Cheat Sheet 05.25.12 | 10:05 am
- Analyst Alerts: Occidental, Pandora, Xueda Education, J&J, SAIC May 24th - Wall St. Cheat Sheet 05.24.12 | 10:05 am
- Hints Of A Market Collapse In The Western World - Seeking Alpha 05.22.12 | 09:05 am
- The Zacks Analyst Blog Highlights: Mylan, Bristol-Myers Squibb, Sanofi, Teva Pharmaceuticals and Dr. Reddy's Laboratories - Press Releases - Zacks 05.22.12 | 09:05 am
- Value Investor Improvement Tip #1: Settle for Cheap Enough - GuruFocus 05.18.12 | 05:05 pm
